iBio, Inc. Common Stock

IBIONASDAQ • USD
0.71 USD
↘ 0.03 (3.65%)🟢LIVE (AS OF 02:00 PM EST)
🟢Market: OPEN

IBIO is currently priced at $0.71. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place IBIO at a fair price relative to peers.

Technical & fundamental data as of Nov 13, 2026.

Open?$0.74
High?$0.77
Low?$0.68
Prev. Close?$0.73
Volume?272.6K
Avg. Volume?714.0K
VWAP?$0.71
Rel. Volume?0.38x
Bid / Ask
Bid?$0.69 × 100
Ask?$0.81 × 100
Spread?$0.11
Midpoint?$0.75
Valuation & Ratios
Market Cap?51.4M
Shares Out?70.5M
Float?55.3M
Float %?86.0%
P/E Ratio?N/A
P/B Ratio?0.65
EPS?-$0.37
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
iBio Inc is a clinical-stage biotechnology company using Artificial Intelligence (AI) for the development of hard-to-drug precision antibodies for obesity, cardiometabolic, and cardiopulmonary diseases. Its product candidate pipeline includes IBIO-610, a monoclonal antibody designed to block Activin E; IBIO-800, a bispecific antibody program targeting myostatin, growth differentiation factor 11 (GDF11), and Activin A; IBIO-600; Amylin Antibody; and Target 4, in different stages of development, being developed as potential therapies for obesity and cardiometabolic disease. The company operates as one reportable segment, which is that of a biotechnology company leveraging AI and ML for the development of hard-to-drug precision antibodies.
Employees
23
Market Cap
51.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2008-08-19
Address
600 MADISON AVENUE, SUITE 1601
NEW YORK, NY 10022-1737
Phone: 302 355-0650
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
0
Momentum?
50
Short Sent.?
29
Piotroski F-Score?3/9Weak
Altman Z-Score?-2.88Distress
Confidence?58%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?7.30%Elevated
Short Interest?4.0M
Days to Cover?7.2
Free Float55.3M
Avg Daily Volume563.7K
Settlement Date2026-10-30
Financial Health
Current Ratio?9.48Strong
Quick Ratio?9.48Strong
Cash Ratio?5.30Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
75/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.65CHEAP▾
P/S?
Peers
100
S&P
3
47.84HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.3CHEAP▾
EV/Sales?
Peers
100
S&P
31
5.58FAIR▾
Returns & Efficiency
ROE?
S&P
6
-33.0%WEAK▾
ROA?
S&P
3
-29.2%WEAK▾
Cash Flow & Enterprise
FCF?$-27588000
Enterprise Value?$6.0M
Fundamentals ratios updated end of day